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Abstract: Recommended psychological treatment for obsessive-compulsive disor-
der (OCD) is cognitive behavioral therapy (CBT) including exposure with response 
prevention (ERP). Previous studies have identified few consistent predictors of both 
short- and long-term treatment outcomes in CBT for OCD. The aim of the current 
study was to investigate the relation between the combined burden of three post-
treatment predictors (subclinical symptoms of OCD, anxiety, and depression) and 
long-term treatment outcome. A total of 97 patients with a diagnosis of OCD from 
an outpatient clinic in Norway completed a concentrated four-day group treatment 
of ERP for OCD. Results revealed that patients in the high-risk group had 2.5 times 
the risk (odds ratio = 10.1) of having OCD at follow-up compared to patients in the 
low risk group. Pre-treatment levels of depression, anxiety and OCD were not signifi-
cantly related to follow-up status. The results indicate an advantage of a combined 
post-treatment predictor model over single pre-treatment predictors. Furthermore, 
we argue that the intensive four-day treatment format provides a unique setting for 
investigating predictors of treatment outcome.
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1. Introduction
Cognitive behavior therapy (CBT) including exposure with response prevention (ERP) typically yields 
clinically significant change for 60–70% of the patients (Öst, Havnen, Hansen, & Kvale, 2015; Öst, 
Riise, Wergeland, Hansen, & Kvale, 2016; Skapinakis et al., 2016). Numerous studies have suggested 
a variety of predictors of treatment outcome in CBT and ERP for obsessive-compulsive disorder 
(OCD), with pre-treatment levels of depression, comorbid anxiety and OCD-severity among the most 
common. A review from 2008 suggests that severe depression pre-treatment, as opposed to mild or 
moderate depression, is related to treatment outcome (Keely, Storch, Merlo, & Geffken, 2008). 
However, the finding is not consistent (Knopp, Knowles, Bee, Lovell, & Bower, 2013; Olatunji, Davis, 
Powers, & Smits, 2013). In a review by Knopp et al. (2013), one third of the included studies found a 
significant relation between anxiety pre-treatment and treatment outcome, but 2/3 did not, so 
again findings diverge. In the same review one third of the included studies reported a significant 
relation between baseline OCD severity and treatment outcome (Knopp et al., 2013). Age and gen-
der have also been found to be related to effect sizes in CBT for OCD (Öst et al., 2015), but not con-
sistently (Olatunji et al., 2013).
In sum, the results are inconsistent or conflicting, and so far no consistent predictors for treat-
ment response have been identified (Keely et al., 2008; Knopp et al., 2013). However, a study using 
post-treatment levels of OCD-symptoms as predictor for long-term treatment outcome shows 
promising results. This study indicated that patients with full remission of OCD had a success rate of 
70%, whereas patients with partial remission had a success rate of merely 45% (Eisen et al., 2013). 
On the other hand, Eisen and colleagues (2013) did not investigate the combined effect of several 
predictors, and only about half of the participants (52%) received CBT. Post-treatment levels of 
symptoms have also been found to predict follow-up status in studies of depression and bipolar 
disorder (Judd et al., 2008; Kiosses & Alexopoulos, 2013). One possible explanation for the better 
predictive value of post-treatment score is that clinical aspects, such as anxiety and depression, are 
addressed directly or indirectly during treatment of OCD, and one could expect less change in such 
symptoms after treatment termination. In light of this, we propose that post-treatment variables 
should be better predictors of long term treatment outcome than pre-treatment predictors.
Previous research has been unable to pinpoint stable single predictors of treatment outcome. 
Research on resilience suggests a cumulative stress model, where elevated levels of stress increase 
the risk for onset and maintenance of psychological problems (Rutter, 2001). Symptoms of depres-
sion, anxiety and OCD have all been linked to increased levels of stress as well as functional impair-
ment (Eisen et al., 2006; Mendlowicz & Stein, 2000; Pruessner, Hellhammer, Pruessner, & Lupien, 
2003). Furthermore, even subthreshold levels of psychiatric symptoms have been linked to increased 
impairment (Eisen et al., 2013; Grabovich, Lu, Tang, Tu, & Lyness, 2010; Olfson et al., 1996). In line 
with this, the combined influence of several predictors should be stronger than the effects of single 
predictors.
Previous predictor studies have displayed several shortcomings. For instance different treatments 
have been offered in different predictor studies (CBT vs. SSRI; in-patients vs. out-patients etc.), mak-
ing it difficult to compare findings. Furthermore, therapist competency is often not controlled for. In 
a newly developed treatment format (Havnen, Hansen, Haug, Prescott, & Kvale, 2013; Havnen, 
Hansen, Öst, & Kvale, 2014, 2017), CBT is delivered during four consecutive days, which dramatically 
reduces unwanted variability in predictor studies, such as extra-therapeutic factors (e.g. effects of 
time, life events, and therapist competency), through shortening the treatment time period and 
thorough therapist training (see closer description of the treatment format below). This approach 
Page 3 of 12
Holm et al., Cogent Psychology (2018), 5: 1461542
https://doi.org/10.1080/23311908.2018.1461542
yields significant acute (one week post treatment) changes in approximately 80% of the patients, 
with 66% being classified as recovered at follow-up, and with practically no patients terminating the 
treatment prematurely (Havnen et al., 2013, 2014). The four-day format thus provides a unique op-
portunity to study long-term treatment response.
In the current study we wanted to investigate if a composite reflecting the combined effect of 
residual symptoms of OCD, anxiety and depression at post-treatment predicts long-term treatment 
outcome. The study was conducted with treatment-seeking patients from an ordinary specialist 
healthcare clinic which yields high ecological validity. We expected that even subclinical levels of 
these factors could represent vulnerability for worse outcome. We also expected that the combined 
power of all three predictors would be stronger than single predictors’ individual effects in relation 
to OCD at follow-up because of the increased burden and possible functional impairment caused by 
them. The identification of strong predictors for treatment outcome is important because it can be 
used to guide individual tailoring of treatment, and to guide future search for consistent predictors 
of outcome. The study is unique in the sense that it uses an intensive group therapy of four days 
instead of a more traditional treatment format, the use of post-treatment predictors instead of pre-
treatment predictors, and that it looks at several risk factors combined as opposed to looking at 
single predictors.
2. Method
2.1. Participants and procedure
The current study is part of a standard quality assurance procedure in an outpatient OCD clinic in 
Norway. The clinic is part of the ordinary specialist healthcare, where all OCD patients in a catchment 
area of about 400,000 inhabitants are referred to the OCD-clinic via their general practitioner and 
local psychiatric department. The patients are granted admission to the OCD-Team if their OCD is 
considered severe enough to need treatment. Using the Mini International Neuropsychiatric 
Interview (Sheehan et al., 1998), trained therapists at the OCD-Team assessed diagnostic status of 
the patients. Patients were offered treatment if they fulfilled the diagnostic criteria of OCD (American 
Psychiatric Association, 2000). The four-day treatment format was not offered if the patient was 
psychotic, suicidal, or had ongoing drug abuse. Furthermore, the patients had to be fluent in 
Norwegian. Patients were urged to discontinue any use of anxiolytics prior to treatment. The ration-
ale for doing so was that patients should not use anxiolytics to regulate their anxiety while doing 
exposure treatment. A total of 32 treatment groups were offered between July 2012 and February 
2016.
As treatment was delivered in a routine care clinic and patients had the right to be granted treat-
ment within 12 weeks after referral, waiting-list was not an option. Patients were offered participa-
tion in the groups whenever there was an open slot. Due to seasonal variation in referrals, group size 
ranged from three to seven patients per group. During the actual period, 15 patients who were ini-
tially offered participation in a treatment group did not participate for various reasons. One patient 
due to substance abuse, one patient needed treatment for an eating disorder, two became sick as 
the group was about to start and one was unable to participate because of a work situation. About 
11 patients did not participate in the first open slot because of sickness or equivalent reasons, but 
later participated in another group. No patients dropped out during the four-day treatment. In the 
current paper, only patients who had responded to all relevant questionnaires and interviews were 
included.
A total of 97 patients (72.2% females) who completed the concentrated treatment were included. 
Age ranged from 18 to 68 years (M = 31.45, SD = 10.38). A total of 43 patients (44%) had one or more 
comorbid psychiatric diagnosis, of which the most common were depression (n = 12, 12.4% of total 
sample), generalized anxiety disorder (n = 10, 10.3%), and social anxiety disorder (n = 5, 5.2%). Forty 
patients (41.2%) reported having received treatment previously for their OCD.
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All patients received the Bergen concentrated exposure treatment (cET). We only outline the 
treatment briefly here, and refer to Havnen et al. (2013, 2014) for more thorough descriptions. The 
four-day format has been labelled individual treatment in a group setting, since the patient-thera-
pist ratio is 1:1. This allows for individually tailored and therapist assisted treatment while simulta-
neously taking advantage of the group setting where the patients can observe change in others and 
offer support. The first day of treatment involves psychoeducation and exposure planning. The sec-
ond and third days are assigned to therapist-assisted exposure. On the fourth day, the patients dis-
cuss “lessons learnt”, and plan self-exposure for the next three weeks. An open trial reports that 
77% of the patients recovered following cET (defined by Yale-Brown Obsessive Compulsive Scale 
(Y-BOCS) score of 14 or below, as well as a reduction of at least 10 points on the Y-BOCS from pre to 
post-treatment), and 65.7% of the patients were classified as recovered at 6 month follow-up 
(Havnen et al., 2014). Furthermore, drop-out rates and rates of people declining treatment have 
been reported to be remarkably low for the four-day treatment format; zero patients dropped out 
and no patients declined treatment in the pilot-study (Havnen et al., 2013).
2.1.1. Therapist competency
All therapists were clinical psychologists or psychiatrists with extensive OCD-relevant clinical experi-
ence (ranging from <1 to 30 years). All had undergone a comprehensive training and certification in 
cET. The training comprises a multiple-choice exam, hands-on clinical training, and supervision from 
experienced cET therapists.
2.1.2. Measures
Pre-treatment measures were filled out by the patients before treatment initiation and returned to 
their therapist when patients attended their screening interview. Post-treatment self-report meas-
ures were completed by the patients one week after termination of the four-day treatment (i.e. after 
one week of self-exposure at home) and returned to the clinic in pre-paid envelopes. Since the cur-
rent study is based on an unselected treatment-seeking patient sample, all measures were collected 
as part of standard quality improvement. Due to this, some of the instruments for anxiety and de-
pression were replaced with briefer screening instruments half-way through the current time-frame. 
The measures were used at pre-treatment, post-treatment, and 6-months follow-up.
2.1.2.1. OCD symptom severity. A clinician assessed patients before treatment using the Y-BOCS in-
terview (Goodman, Price, Rasmussen, Mazure, Fleischmann, et al., 1989). An independent assessor 
conducted Y-BOCS interviews by phone one week after termination of treatment and at follow-up (3 
and 6 months post-treatment). All clinicians completing the Y-BOCS interview were specifically 
trained in the procedure. The Y-BOCS interview has been shown to have good psychometric proper-
ties, and to be sensitive to change after treatment (Goodman, Price, Rasmussen, Mazure, Delgado, 
et al., 1989; Goodman, Price, Rasmussen, Mazure, Fleischmann, et al., 1989).
The Y-BOCS 6-month score was used as indicator of long-term treatment response. We merged 
data from the two Y-BOCS follow-up assessments, using the 6-month follow-up data when available 
(n = 79) and supplementing with 3-month follow-up data when 6-month follow-up (n = 18) were 
unavailable. A paired-samples t-test showed no significant difference between the 3-month scores 
and the 6-month scores (t(65) = −1.33, p = .19, mean difference = −.95).
2.1.2.2. Anxiety. The patients who participated in the first treatment groups (about half of the pa-
tients) filled out Beck Anxiety Inventory (BAI; Beck, Epstein, Brown, & Steer, 1988). The patients who 
participated in the remaining groups filled out the Generalized Anxiety Disorder 7-item scale (GAD-7; 
Spitzer, Kroenke, Williams, & Löwe, 2006). This is a briefer self-report measure which has shown 
good reliability and validity (Löwe et al., 2008). Both GAD-7 and BAI has been proved to yield a good 
measurement of anxiety (Beck & Steer, 1991; Spitzer et al., 2006). Furthermore, the correlation be-
tween GAD-7 and BAI has been reported to be strong (r = .72), supporting the assumption that the 
two measures assess similar aspects of anxiety (Spitzer et al., 2006).
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2.1.2.3. Depression. Patients from about half of the treatment groups filled out Beck Depression 
Inventory, revised version (BDI-II; Beck, Steer, & Brown, 1996), which has been shown to have good 
psychometric properties (Titov et al., 2011). The second half of patients filled out the Patient Health 
Questionnaire (PHQ-9; Spitzer, Kroenke, Williams, & Patient Health Questionnaire Primary Care Study 
Group, 1999), which gives a briefer measure of depressive symptoms. The PHQ-9 has been shown to 
be an adequate screening instrument for depression both in medical settings (Gilbody, Richards, 
Brealey, & Hewitt, 2007) and in the general population (Martin, Rief, Klaiberg, & Braehler, 2006), and 
has been found to correlate strongly with BDI-II (r = .72–.77; Kung et al., 2013; Titov et al., 2011).
2.1.2.4. Cut-off criteria for predictor variables. Cut-off points were set to differentiate a dichotomous 
high risk vs. low-risk group variable where the low-risk group showed none or very mild symptoms, 
whereas the high risk group showed mild to severe symptoms at post-treatment. The cut-off criteria 
also had to yield a similar proportion of high risk and low risk participants when using either the BAI 
or the GAD-7, as well as for the BDI-II and the PHQ-9.
The cut-off criteria were set to 9 for GAD-7 (Spitzer et al., 2006) and BAI (Julian, 2011), correspond-
ing to mild anxiety. With these cut-off criteria, 56.8% of the patients who had answered the BAI and 
54.7% of the patients who had filled out GAD-7 were classified as “at risk”.
For the PHQ-9 the cut-off criterion was set to 12 (Löwe et al., 2004), and for BDI-II it was set to 13 
(Salkind, 1969), corresponding to mild depression. With these criteria, 34.1% of the patients who 
filled out BDI-II, and 37.7% of the patients who filled out the PHQ-9 were classified as “at risk”.
For symptoms of OCD the cut-off criterion was set to 11 on the Y-BOCS, i.e. mild OCD (between 
asymptomatic and cut-off suggested by Fisher & Wells, 2005). This cut-off criterion placed 47.4% of 
the patients in the “at risk” group.
Patients were defined as “high risk” if they scored above cut-off on all three scales (anxiety, de-
pression and Y-BOCS post-treatment), and “low risk” if they scored below cut-off on at least one of 
the scales. Details of mean scores and standard deviations on Y-BOCS, BDI, BAI, PHQ-9 and GAD-7 
are displayed in Table 1.
2.2. Statistical analyses
The maximum amount of missing items per questionnaire for this sample was 2. Missing items were 
replaced with the average score on the questionnaire for the individual patient.
Treatment status at follow-up was based on Y-BOCS scores. Clinical meaningful change was inves-
tigated using criteria recommended by Mataix-Cols et al. (2016), which states that a patient can be 
considered in remission with a Y-BOCS score of ≤12, and that a change in Y-BOCS score of ≥35% can 
be considered a significant treatment response. In order to assess the predictors individually we 
used three chi-square (χ2) tests checking whether high vs. low-scorers on depression, anxiety and 
Y-BOCS post-treatment were related to remission status at follow-up (i.e. Y-BOCS above or at/below 
12).
A multiple regression analysis was also used to investigate the predictive effects of continuous 
variables (age, gender and post-treatment scores on anxiety, depression and OCD) on Y-BOCS fol-
low-up scores. To incorporate different measures of depression and anxiety in the analysis, depres-
sion and anxiety scores were converted to z-scores before running the analysis. We controlled for 
age and gender in all regression analyses, based on the findings that age and gender might be sig-
nificantly related to effect sizes in studies of CBT for OCD (Öst et al., 2015).
To further investigate the relationship between predictors and follow-up status, we ran three lo-
gistic regression analyses. Logistic regression analyses were chosen because it provides a way of 
dealing with the different measures applied in the clinic. Through dichotomizing the variables we 
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aimed at equalizing the different predictors so that it would be possible to combine them into single 
predictors (anxiety and depression), yielding better power than the different measures by them-
selves. Furthermore, the use of dichotomous cut-off criteria might be easier and more intuitive to 
apply in the clinic compared to continuous variables for identifying patients at risk. The question-
naires are often used in this way in the clinic as the forms have cut-offs for mild, moderate and se-
vere levels of distress. In the first logistic regression analysis, age, gender and all three risk factors 
were entered separately as independent variables. Y-BOCS-score at follow-up (above or at/below 12) 
was entered as dependent variable. In the second logistic regression analysis, age, gender and the 
aforementioned new variable (“high risk” vs. “low risk” patients’) were entered as independent vari-
ables, and again categorical Y-BOCS score at follow-up was entered as dependent variable. Then we 
ran the second analysis again, this time excluding all patients who had not recovered post-treat-
ment (i.e. Y.BOCS > 12) to make sure the results in the second regression analysis were not a product 
of non-recovered patients scoring high on the Y-BOCS both post-treatment and at follow-up. We 
converted odds ratio to risk ratio using online software (http://clincalc.com).
We then investigated patients who relapsed vs. patients who remained in remission with t-tests, 
to find out whether there was a significant difference in demographic factors (age and gender) as 
well as risk factors for relapsed vs. non-relapsed patients. Relapse was defined using criteria sug-
gested by Mataix-Cols et al. (2016); the patient initially responded to treatment (defined by a Y-BOCS 
score of 12 or lower) and no longer met this criteria at follow-up (i.e. a Y-BOCS score of 13 or higher). 
This procedure was not performed for responders (i.e. failing to meet the 35% reduction criteria after 
initial response and remission) as suggested by Matiax-Cols and colleagues (2016), as this applied 
for only two patients.
Table 1. Measures of psychiatric symptoms
Notes: Y-BOCS = Yale-Brown Obsessive Compulsive Scale, GAD-7 = Generalized Anxiety Disorder 7-item scale, BAI = Beck 




 Y-BOCS 97 25.26 5.07
Anxiety
 GAD-7 56 12.05 5.37
 BAI 25 19.24 11.32
Depression
 PHQ-9 53 13.23 5.69
 BDI 43 17.58 9.96
Post-treatment predictors 
Obsessive-compulsive symptoms
 Y-BOCS 97 10.13 4.68
Anxiety
 GAD-7 53 9.68 5.06
 BAI 44 12.30 8.82
Depression
 PHQ-9 53 9.74 5.50
 BDI-II 44 12.04 9.43
Follow-up measure
 Y-BOCS 97 11.86 6.93
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Finally, to examine whether post-treatment predictors were truly better related to follow-up sta-
tus, we investigated whether pre-treatment levels of depression (measured with PHQ-9), anxiety 
(measured with GAD-7) and OCD (measured with Y-BOCS) were related to Y-BOCS scores at follow-
up using bivariate correlations. A hierarchical linear regression analysis was then run to investigate 
the effects of age, gender, anxiety pre-treatment (measured with GAD-7), depression pre-treatment 
(measured with PHQ-9) and Y-BOCS pre-treatment on Y-BOCS score at follow-up. The pre-treatment 
measures were not analyzed using logistic regression analyses as described above, as all patients 
scored above cut-off on OCD before treatment. T-tests were used to investigate whether mean 
scores on pre-treatment characteristics (age, gender, Y-BOCS scores, GAD-7 scores and PHQ-9 
scores) were different for remission vs. non-remission (i.e. Y-BOCS ≤ 12) post-treatment.
3. Results
Nearly 90% (87.6% (n = 85)) of the patients responded to treatment (i.e. had a reduction in symp-
toms of 35% or more from pre- to post-treatment). The corresponding figure for follow-up was 
74.2%. Seventy-two patients (74.2%) were in remission (Y-BOCS ≤ 12) post-treatment, and 56.7% 
had symptom remission at follow-up. Mean Y-BOCS scores at pre- and post-treatment and follow-up 
are displayed in Table 1.
When applying the cut-off criteria as described above for the risk factors, 46 patients (47.4%) 
scored above cut-off on OCD (Y-BOCS ≥ 11), 54 (55.7%) scored above cut-off on anxiety and 35 
(36.1%) scored above cut-off on depression post-treatment. When counting number of risk factors, 
25 patients had no risk factors, 27 patients had 1 risk factor, 27 patients had 2 risk factors and 18 
patients had all three risk factors. In other words, 18 patients were in the “high risk group”, display-
ing all three risk factors, while 79 patients were in the “low risk” group, displaying 2 or less risk fac-
tors. In the last logistic regression analysis where non-responders were removed from the analysis, 
8 patients were classified as “high risk” and 64 patients were classified as “low risk”.
Three χ2 tests were performed to investigate the relation between “at risk” scores on depression, 
anxiety and Y-BOCS post-treatment and remission at follow-up. We found a significant relation be-
tween OCD follow-up status and depression post-treatment (χ2 (1, N = 97) = 8.53, p = .003), anxiety 
post-treatment (χ2 (1, N = 97) = 5.37, p = .02) as well as Y-BOCS score post-treatment (χ2 (1, 
N = 97) = 6.23, p = .013). All three risk factors were significant as single predictors of long-term 
outcome.
A multiple regression analysis was also used to investigate the predictive effect of continuous 
variables (i.e. age, gender and post-treatment scores on anxiety, depression and OCD) on Y-BOCS 
scores at follow-up. The results of the regression indicated the predictors explained 23% of the vari-
ance (R2 = .23, F(5,91) = 5.53, p < .01). However, the only significant predictor was Y-BOCS post treat-
ment (p < .01). Neither; age (p = .09), gender (p = .42), anxiety post-treatment (p = .09) nor depression 
post-treatment (p = .87) significantly contributed to the model.
A logistic regression analysis was used to investigate the predictive effects of age, gender, and all 
three risk factors separately for remission status at follow-up. Age (p = .072), gender (p = .59) and 
anxiety scores post-treatment (p = .48) were not significantly related to remission status at follow-
up. Symptoms of depression (p < .05) and OCD (p < .05), on the other hand, were significantly related 
to remission at follow-up. All logistic regression analysis results are presented in Table 2.
A second logistic regression analysis investigated the effects of low vs. high-risk patients for re-
mission status at follow-up. Age and gender were again added to the regression. Whereas age 
(p = .21) and gender (p = .39) were not significant contributors to the model, having three risk factors 
(i.e. high scores on depression, anxiety and OCD post-treatment) was significantly associated with 
worse outcome (p < .01). As can be seen in Table 2, this yielded an odds ratio of 10.09. Converting 
this odds ratio to risk ratio gave a risk ratio of 2.46. Figure 1 displays graphically how the number of 
risk factors lowered treatment success rate.
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Then we reran the second logistic regression analysis, excluding the patients who had not recov-
ered post-treatment (n = 25). Age (p = .07) and gender (p = .71) were not significant contributors to 
the model. Having all three risk factors was significantly related to worse outcome (p < .05), again 
with a high odds ratio (8.71; risk ratio 2.65).
We then investigated relapsed vs. non-relapsed patients as defined above, excluding patients who 
did not respond to treatment initially (i.e. Y-BOCS > 12 post-treatment). Twenty-five patients re-
lapsed between post-treatment and follow-up. Mean change in Y-BOCS score from post-treatment 
to follow-up for the relapse group was 8.76 (SD = 6.75). Average Y-BOCS score at follow-up was 6.87 
Table 2. Summary of logistic regression analysis for post-treatment variables predicting 
symptom remission at follow-up
Notes: eB = exponential B, Depression, anxiety and Y-BOCS score post-treatment coded as 1 for at risk and 0 for not at 
risk. Y-BOCS score at follow-up coded as 1 if ill at follow-up (i.e. Y-BOCS > 12), and 2 if symptom remission at follow-up 
(i.e. Y-BOCS ≤ 12). In analysis 1, age, gender and all three risk factors were entered separately as independent predictors. 
In analysis 2, age, gender and having all three risk factors were entered as independent variables. The third analysis was 
identical to the second, except for the exclusion of patients not recovered post-treatment. Y-BOCS-score at follow-up 
(above or at/below 12) was entered as dependent variable for all three analyses.
B SE B eB p
Analysis 1 (n = 97)
 Age −.04 .02 .96 .07
 Gender .27 .51 1.31 .59
 Depression 1.17 .55 3.21 .03
 Anxiety .37 .53 1.45 .48
 OCD symptoms 1.02 .47 2.77 .03
Analysis 2 (n = 97)
 Age −.03 .02 .97 .21
 Gender .42 .50 1.53 .39
 3 Risk factors 2.31 .69 10.09 <.01
Analysis 3 (n = 72)
 Age −.05 .03 .95 .07
 Gender .23 .63 1.26 .71
 3 Risk factors 2.16 .89 8.71 .02
Figure 1. Remission rates at 
follow-up decrease with each 
added post-treatment risk 
factor.
Notes: The panel displays the 
percentage of patients scoring 
below clinical cut-off (i.e. <12) 
on the Y-BOCS at follow-up for 
patients having 0, 1, 2 or 3 risk 
factors (scores above cut-off 
on depression, anxiety and/or 
Y-BOCS at post-treatment).
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for the non-relapsed group and 17.40 for the relapsed group, and the difference was significant 
(t(72) = 9.88, p < .001). The corresponding figures for pre-treatment and post-treatment Y-BOCS 
scores were 25.30 and 7.94 for the non-relapsed group and 24.24 and 8.64 for the relapsed group. 
Neither pre-treatment scores (t(72) = .91, p = .37), nor post-treatment scores (t(72) = −.86, p = .39) 
were significantly different between the two groups. T-tests revealed no differences in age 
(t(72) = 1.65, p = .10) nor gender (t(72) = .26, p = .80) between the relapse vs. non-relapse patients. 
However, the relapse group had significantly more risk-factors post-treatment (M = 1.52, medi-
an = 2, mode = 2, SD = .1.16) compared to the non-relapse group (M = .94, median = 1, mode = 0, 
SD = .89), t(72) = 2.38, p < .05).
To examine whether post-treatment predictors were better related to follow-up status than pre-
treatment predictors, we investigated the correlation between pre-treatment levels of depression, 
anxiety, and OCD and Y-BOCS scores at follow-up. Neither symptoms of depression (r = −.02, n = 65, 
p = .88), anxiety (r = −.07, n = 67, p = .57) nor OCD (r = −.02, n = 97, p = .88) at pre-treatment were 
significantly correlated with follow-up status. We ran a hierarchical regression analysis to investi-
gate the relation further. The regression equation was not significant (F(5,58) = .97, p = .45). Neither 
age (p = .14), gender (p = .94), anxiety pre-treatment (p = .09), depression pre-treatment (p = .25) 
nor OCD pre-treatment (p = .71) were significantly related to follow-up status. In summary, none of 
the risk factors pre-treatment were significantly related to follow-up status.
Having investigated pre-treatment predictors for follow-up status, we finally investigated pre-
treatment predictors of post-treatment status. Independent sample t-tests were used to investigate 
whether mean scores on pre-treatment characteristics were different for patients in remission vs. 
not in remission post-treatment. Whereas age (t(95) = .12, p = .90), OCD (t(95) = −.08, p = .28), anxi-
ety (t(65) = .13, p = .89) and depression (t(63) = 1.09, p = .28) were not significantly different for re-
mission vs. non-remission, gender was significantly different for the two groups (t(95) = −2.12, 
p < .05), with a larger proportion of men in the non-remission group (44%) compared with the remis-
sion group (22%).
4. Discussion
We investigated the relation between post-treatment risk factors and OCD symptom severity at 
follow-up using an unselected sample of treatment-seeking OCD patients receiving cET in the spe-
cialist health care. Nearly 90% of the patients responded to treatment initially, and 74.2% were in 
remission (Y-BOCS ≤ 12) post-treatment. The corresponding numbers for follow-up status were 
74.2% responders and 56.7% in remission. Our results showed that patients with mild to moderate 
symptoms on measures of OCD-symptom severity, depression and anxiety at post-treatment had 
2.5 times the risk (odds ratio = 10.1) of having OCD at follow-up. The results still held true when re-
moving non-recovered patients from the analysis (odds ratio = 8.71). As can be seen in Figure 1, 
each additional risk factor seems to add risk for reduced treatment outcome. Patients who relapsed 
had significantly more risk factors post-treatment than non-relapsed patients. Pre-treatment levels 
of anxiety, depression and OCD, however, were not significantly related to Y-BOCS score at 
follow-up.
Previous studies have been inconsistent regarding the relation between pre-treatment levels of 
anxiety, depression and OCD-symptoms and treatment outcome (Keely et al., 2008; Knopp et al., 
2013). The current study shows that pre-treatment predictors have weak predictive validity. However, 
the study revealed a strong relation between post-treatment predictors and long-term treatment 
outcome. Our study encourages the use of post-treatment predictors for long-term outcome. Eisen 
and colleagues (2013) found that patients with full remission of OCD symptoms had a success rate 
of 70%, while patients with partial remission had a 40% success rate. The corresponding figures in 
our study indicated that patients with 0 risk factors had a 72.0% success rate, while the patients with 
3 risk factors had a success rate of 16.7% (see Figure 1). Furthermore, in our study the treatment was 
better controlled, as all patients received the four-day format delivered by trained therapists, while 
in the study by Eisen and colleagues, only 52% of the patients received CBT. In the study by Eisen et 
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al., 36 patients had full remission and 47 patients had partial remission, and 59% relapsed. In our 
study, more people responded to treatment, less people relapsed and the predictive model proved 
stronger. Findings from the current study therefore replicates the study by Eisen et al. and extends 
it by showing that it is also important to monitor for symptoms of anxiety and depression in patients 
with OCD.
Furthermore, the study revealed a strong predictive effect of the combined burden of several post-
treatment predictors. Our results underscore the importance of using several predictors as opposed 
to single predictors when investigating treatment outcome for psychiatric disorders, which are often 
complex and multifaceted. This is in line with research on the cumulative stress model from the re-
silience literature, which states that cumulative levels of stress increases the risk of maintenance of 
psychological problems (Rutter, 2001). While the patient might cope in face of moderate depression 
alone, the combined effects of depression, anxiety and OCD-symptoms could overwhelm the patient 
and might contribute to the higher OCD severity scores found in the high risk group. Several studies 
have investigated pathways through which stress can influence health (Rod, Grønbaek, Schnohr, 
Prescott, & Kristensen, 2009; Steptoe, 1991). For instance, Steptoe (1991) and Rod and colleagues 
(2009) highlight how stress can influence health related behaviors, such as smoking, alcohol use and 
regular exercise, thus possible worsening the burden for the patient.
Finally, our study supports the use of cut-off criteria for estimating risk of relapse as the multiple 
regression analysis using continuous variables were not able to identify the risk of having residual 
symptoms. We also argue the use of cut-off criteria is intuitive and easy to apply in the clinic to 
identify patients at risk of relapsing.
4.1. Strengths and limitations
One important limitation concerns the use of two different measures for anxiety (BAI and GAD-7) as 
well as for depression (BDI-II and PHQ-9). This was a result of the current study being part of the 
quality assurance procedures at an outpatient clinic in its early stages. We made careful steps to 
make the measures as equal as possible through matching the cut-off criteria and using categorical 
analyses. This allowed us to get a bigger sample, thus overall strengthening the analyses. Post-hoc 
we ran the main logistic regression analysis again, with only (1) PHQ-9, GAD-7 and Y-BOCS as risk 
factors, and (2) BDI, BAI and Y-BOCS as risk factors, both analyses controlling for age and gender. In 
the first analysis, the risk factors came out significantly related to follow-up status (p < .01), whereas 
in the second they did not (p = .10). Hence, GAD-7 and PHQ-9 might be better predictors of follow-up 
status and pick up different aspects of anxiety and depression than BDI and BAI. However, only 
seven patients were classified as “high risk” in the BDI/BAI analysis, making the sample size too 
small to draw firm conclusions. Another limitation concerns the urge of discontinuing use of anxio-
lytics prior to treatment. This was not monitored formally, and the discontinuation might possibly 
increase symptoms pre-treatment, representing a confounding variable.
Previous reports of the four-day treatment format have indicated that hardly any patients decline 
treatment, and that there are very few drop-outs (Havnen et al., 2013), yielding a sample with high 
ecological validity. Since the intervention is so concentrated, it reduces unwanted variability related 
to external factors confounding short-term treatment outcome. Also, since the intervention is clear-
ly potent as indicated by nearly 90% of the patients being classified as responders post-treatment, 
it represents an ideal setting for studying post-treatment predictors for long-term outcome. Future 
studies should investigate whether our findings also hold true in a standard CBT format.
5. Conclusion and implications
The study found a strong association between the combined effects of post-treatment scores of 
depression, anxiety and OCD-symptoms and high Y-BOCS scores at follow-up. This collection of 
symptoms could indicate vulnerability for relapse. Our results indicate that clinicians should be 
aware of patients displaying these residual symptoms at the end of the treatment period, and may-
be pay special attention to these patients in the period following treatment. We recommend future 
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research to investigate alternative treatments for non-responders and patients with relapse, for 
example treatment with d-cycloserine and exposure therapy combined (Kvale & Hansen, 2016). We 
also recommend future research to use both pre- and post-treatment predictors when investigating 
predictors of treatment outcome.
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